Launching Astepro Allergy in the US following a successful Rx-to-OTC switch helped Bayer Consumer Health’s Allergy & Cold category post a double-digit rise in sales in the third quarter.
Astepro Launch And Strong Cold Season Boost Bayer In Q3
The US OTC launch of reclassified nasal spray Astepro Allergy, in combination with “continuously elevated cold incidence rates,” helped to drive up Bayer's Consumer Health sales at a double-digit rate in Q3.